CORC

浏览/检索结果: 共8条,第1-8条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Genome-wide microRNA expression profiling in malignant pleural effusion to identify a ten-microRNA signature. 会议论文
作者:  Zhang, Xin;  Zhang, Meiling;  Zhu, Miaojun;  Hu, Qin;  Li, Chun
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Genome-wide microRNA expression profiling in malignant pleural effusion to identify a ten-microRNA signature 期刊论文
Journal of Clinical Oncology, 2017, 卷号: 35
作者:  Zhang M., Zhu M., Hu Q., Li C., Zhu Z., Hou Y., Xu J., Wang H., Zhu T., Tang T., Tan R., Zhang X.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion. 期刊论文
Postgraduate Medicine, 2017, 页码: 1-5
作者:  Chen M;  Xie S;  Wan C;  Zeng N;  Wu Y
收藏  |  浏览/下载:6/0  |  提交时间:2019/02/25
Immune Regulation of Toll-Like Receptor 2 Engagement on CD4 T Cells in Murine Models of Malignant Pleural Effusion 期刊论文
American Journal of Respiratory Cell and Molecular Biology, 2017, 卷号: Vol.56 No.3, 页码: 342 –352
作者:  Xiu-Zhi Wu;  Qiong Zhou;  Hua Lin;  Kan Zhai;  Xiao-Juan Wang
收藏  |  浏览/下载:6/0  |  提交时间:2019/03/26
Toll-like  receptor  2  malignant  pleural  effusion  Th17  cells  Th9  cells  Th2  cells  
Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion 期刊论文
POSTGRADUATE MEDICINE, 2017, 卷号: Vol.129 No.6, 页码: 644-648
作者:  Chen, Mei;  Xie, Shenglong;  Wan, Chun;  Zeng, Ni;  Wu, Yanqiu
收藏  |  浏览/下载:4/0  |  提交时间:2019/02/25
Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 68, 页码: 112809-112815
作者:  Shan, Yi[1];  Ding, Hui[2];  Lu, Junjie[3];  Ge, Zhijun[4];  Tan, Yongfei[5]
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/24
MAC30  MPE  NSCLC  BPE  OS  
ROS1 (D4D6) is Reliable for Innmunohisochemistry Detecting of ROS1 Fusion Lung Adenocarcinoma in Malignant Pleural Effusion 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S487-S488
作者:  Wang, Zheng;  Liu, Dongge;  Shi, Yuankai;  Mu, Xinlin;  Han, Xiaohong
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03
Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analy 期刊论文
2017, 卷号: 12, 期号: 11, 页码: S2084-S2084
作者:  Li, X.;  Li, J.
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace